superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2025-03-31
- Valid until
- 2025-06-30
- Published
- 2025-04-30
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 2,052,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Abbott Laboratories quarterly operating income: 1,693,000,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_75BE91C87765, https://asof.is/claim/clm_75BE91C87765, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm.
APA
AsOf. (2025). Abbott Laboratories quarterly operating income: 1,693,000,000 United States dollar (as of 2025-03-31 (until 2025-06-30)) [Record clm_75BE91C87765]. Retrieved November 9, 2026, from https://asof.is/claim/clm_75BE91C87765 (source: https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm)
BibTeX
@misc{asof_clm_75BE91C87765,
author = {AsOf},
title = {Abbott Laboratories quarterly operating income: 1,693,000,000 United States dollar},
year = {2025},
howpublished = {\url{https://asof.is/claim/clm_75BE91C87765}},
note = {Claim clm\_75BE91C87765, as of 2025-03-31 (until 2025-06-30); source: https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_75BE91C87765.md/v1/claims/clm_75BE91C87765submit a correction